海王生物
(000078)
| 流通市值：76.17亿 | | | 总市值：76.30亿 |
| 流通股本：26.26亿 | | | 总股本：26.31亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 24,552,692,705.95 | 16,631,439,699.61 | 8,087,937,989.71 | 36,418,770,306.16 |
| 营业收入 | 24,552,692,705.95 | 16,631,439,699.61 | 8,087,937,989.71 | 36,418,770,306.16 |
| 二、营业总成本 | 24,375,198,874.25 | 16,469,747,831.28 | 7,981,269,889.39 | 36,503,984,042.96 |
| 营业成本 | 22,121,950,620.2 | 14,958,533,023.89 | 7,245,189,928.1 | 32,865,445,209.55 |
| 税金及附加 | 70,567,336.46 | 47,493,178.65 | 22,928,320.76 | 107,023,923.22 |
| 销售费用 | 852,773,520.74 | 567,284,856.71 | 282,240,166.46 | 1,390,073,485.34 |
| 管理费用 | 762,836,836.89 | 508,135,561.9 | 241,419,534.28 | 1,149,882,564.47 |
| 研发费用 | 32,134,928.15 | 21,528,588.81 | 10,122,756.35 | 47,938,144.82 |
| 财务费用 | 534,935,631.81 | 366,772,621.32 | 179,369,183.44 | 943,620,715.56 |
| 其中:利息费用 | 549,294,606.07 | 375,496,773.81 | 205,615,289.37 | 945,944,671.94 |
| 其中:利息收入 | 47,666,952.01 | 29,235,153.98 | 27,569,817.29 | 48,791,229.42 |
| 加:公允价值变动收益 | 10,026,809.34 | 254,336.16 | 115,975.62 | 17,752,259.55 |
| 加:投资收益 | -4,706,603.43 | -9,469,425.89 | -8,007,570.45 | -45,417,836.01 |
| 资产处置收益 | 5,827,945.59 | 5,463,104.04 | 602,905.61 | 3,237,874.71 |
| 资产减值损失(新) | 941,215.41 | 6,422,504.73 | 956,100.6 | -962,354,680.99 |
| 信用减值损失(新) | 48,537,615.61 | 34,194,312.43 | 15,708,477.13 | -423,166,269.24 |
| 其他收益 | 28,873,635.32 | 15,224,888.09 | 5,716,405.89 | 27,132,469.03 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 266,994,449.54 | 213,781,587.89 | 121,760,394.72 | -1,468,029,919.75 |
| 加:营业外收入 | 12,143,263.61 | 7,182,845.46 | 1,794,416.78 | 25,025,619.79 |
| 减:营业外支出 | 10,259,638.38 | 5,924,366.32 | 1,916,688.18 | 15,469,995.21 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 268,878,074.77 | 215,040,067.03 | 121,638,123.32 | -1,458,474,295.17 |
| 减:所得税费用 | 143,032,719.25 | 99,758,584.37 | 52,466,567.19 | 260,558,561.15 |
| 六、净利润 | 125,845,355.52 | 115,281,482.66 | 69,171,556.13 | -1,719,032,856.32 |
| 持续经营净利润 | 125,845,355.52 | 115,281,482.66 | 69,171,556.13 | -1,719,032,856.32 |
| 归属于母公司股东的净利润 | 46,217,326.63 | 45,409,831.68 | 42,641,426.53 | -1,689,944,687.46 |
| 少数股东损益 | 79,628,028.89 | 69,871,650.98 | 26,530,129.6 | -29,088,168.86 |
| (一)基本每股收益 | 0.02 | 0.02 | 0.02 | -0.64 |
| (二)稀释每股收益 | 0.02 | 0.02 | 0.02 | -0.64 |
| 八、其他综合收益 | -790,000 | -790,000 | - | -17,430,000 |
| 归属于母公司股东的其他综合收益 | -790,000 | -790,000 | - | -17,430,000 |
| 九、综合收益总额 | 125,055,355.52 | 114,491,482.66 | 69,171,556.13 | -1,736,462,856.32 |
| 归属于母公司股东的综合收益总额 | 45,427,326.63 | 44,619,831.68 | 42,641,426.53 | -1,707,374,687.46 |
| 归属于少数股东的综合收益总额 | 79,628,028.89 | 69,871,650.98 | 26,530,129.6 | -29,088,168.86 |
| 公告日期 | 2024-10-31 | 2024-08-31 | 2024-04-30 | 2024-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |